White matter microstructure of superior longitudinal fasciculus II is associated with intelligence and treatment response of negative symptoms in patients with schizophrenia

• Published in: NPJ schizophrenia Vol. 8; no. 1; p. 43
• Main Authors: Lee, Joonho, Oh, Jong-Soo, Park, Chun-Il, Bang, Minji, Sung, Gihye, Jung, Sra, Lee, Sang-Hyuk
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27-04-2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378/1689/1799; 692/699/476/1799; Brain; Clinical outcomes; Cognitive ability; Cognitive Psychology; Magnetic resonance imaging; Medicine; Medicine & Public Health; Microstructure; Neurology; Neurosciences; Psychiatry; Psychosis; Psychotropic drugs; Respiratory distress syndrome; Schizophrenia
• ISSN: 2754-6993; 2754-6993; 2334-265X
• DOI: 10.1038/s41537-022-00253-9

Although the potential role of superior longitudinal fasciculus (SLF) in intellectual deficits and treatment response (TR) in patients with schizophrenia (SZ) has been previously described, little is known about the white-matter (WM) integrity of SLF subcomponents (SLF I, II, III, and arcuate fasciculus) and their particular relationships with the clinical presentations of the illness. This study examined the associations between fractional anisotropy (FA) of SLF subcomponents and intelligence level and 6-month treatment response (TR) of negative symptoms (NS) in patients with SZ. At baseline, 101 patients with SZ and 101 healthy controls (HCs) underwent structural magnetic resonance imaging. Voxel-wise group comparison analysis showed significant SLF FA reductions in patients with SZ compared with HCs. Voxel-wise correlation analyses revealed significant positive correlations of FAs of right SLF II with Korean–Wechsler Adult Intelligence Scale at baseline and the percentage reduction of negative syndrome subscale of the Positive and Negative Syndrome Scales at 6 months. These findings suggest that aberrance in WM microstructure in SLF II may be associated with intellectual deficits in patients with SZ and TR of NS, which may support the potential role of SLF II as a novel neuroimaging biomarker for clinical outcomes of the illness.